%0 Journal Article %T Lung retransplantation: walking a thin line between hope and false expectations %A Godinas, Laurent %A Raemdonck, Dirk Van %A J. Ceulemans, Laurens %A Vos, Robin %A Verleden, Geert M. %J Journal of Thoracic Disease %D 2019 %B 2019 %9 %! Lung retransplantation: walking a thin line between hope and false expectations %K %X Lung transplantation is a recognized treatment for end-stage lung disease for selected patients for whom no other options are available (1). Since the introduction of calcineurin inhibitors in the 1980’s, lung transplantation became a reasonable treatment with improved outcomes (2). However, chronic rejection or chronic lung allograft dysfunction (CLAD) remains the major limitation for long-term survival (3,4), accounting for more than 40% of deaths beyond the first year after pulmonary transplantation (4). CLAD leads to a progressive and irreversible loss of function of the transplanted organ. %U https://jtd.amegroups.org/article/view/33053 %V 11 %N 11 %P E200-E203 %@ 2077-6624